Episode Details

This episode explores the critical process of switching your Indian Authorized Agent (IAA) with the CDSCO, moving from a commercially-tied distributor to an independent regulatory partner. We detail the significant business risks of using a distributor as your agent and provide a step-by-step guide for making the change, including the crucial role of the No-Objection Certificate (NOC). Learn how an independent IAA provides commercial flexibility and secures your long-term market access in India. Key Questions: • What are the primary responsibilities of an Indian Authorized Agent (IAA)? • Why is it risky to appoint your distributor as your legal representative in India? • What is a No-Objection Certificate (NOC) and why is it essential for changing your IAA? • Is it possible to transfer an existing CDSCO import license to a new agent? • What is the official process for appointing a new independent IAA with the CDSCO? • How does an independent IAA grant you more control over your commercial strategy? • What documents are required to prove no changes have been made to the device during the switch? • How can this change protect your business from being held hostage by a commercial partner? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email info@pureglobal.com for tailored support.